BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  With Pivotal WHIM Readout Ahead, 2022 Could be Decisive Year for X4

  Boston-based X4 Pharmaceuticals reported its first-quarter financial report today. Of note was the company’s cash, cash equivalents & restricted cash, which was $67.7 million as of March 31, 2022.

  May 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Cullinan Oncology and Taiho Reunite to Co-Develop NSCLC Drug

  Cullinan and Taiho announced that Taiho was acquiring Cullinan Pearl and will co-develop and co-commercialize their non-small cell lung cancer drug.

  May 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  BMS & BridgeBio Team Up in Nearly $1B Oncology Pact

  BridgeBio announced it has signed an exclusive deal with Bristol-Myers Squibb to develop and commercialize a potential treatment for cancer.

  May 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Business

  Sana’s Terry Fry to Spearhead New Regenerative, Cell & Gene Therapy Endeavor

  Dr. Terry Fry, M.D., a leader in chimeric antigen receptor T-cell (CAR-T) therapies and senior vice president, head of T-cell therapeutics at Sana Biotechnology, will be heading the newly created Gates Institute.

  May 12, 2022

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Scientists Rejuvenate Skin Cells by 30 Years, with Pioneering Potential

  A group of scientists from the Babraham Institute in the United Kingdom has successfully rejuvenated skin cells by 30 years, observing several benefits of the functionally younger cells.

  May 12, 2022

   · 

  4 min read

   · 

  Abbey Glasure
• 

  Policy

  Police Documents Reveal Details Of Allegations Against Seagen Founder

  Police documents reveal a May 2 dated TRO against Siegall concerning a fourth degree domestic violence gross misdemeanor charge.

  May 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Stealth Clinches Orphan Drug Designation in DMD

  Stealth BioTherapeutics has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for elamipretide.

  May 12, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Research Roundup: Stressing Cells May Mitigate Dementia and Another Clue to Parkinson’s Disease

  Tangles of toxic proteins are associated with various dementias, such as Alzheimer’s disease. Often, these tangles are misfolded proteins. Now, researchers have identified a new mechanism that might reverse the build-up of these aggregates.

  May 12, 2022

   · 

  6 min read

   · 

  Mark Terry
• 

  Policy

  Biden Commemorates 1M Lives Lost to COVID, Urges Congress to Act

  On Thursday at the White House, President Biden paid tribute to the 1 million American lives lost due to COVID-19.

  May 12, 2022

   · 

  2 min read

   · 

  Rosemary Scott
• 

  Business

  BioSpace Movers & Shakers: Singular Genomics, Marengo, Ventyx, Caribou and More

  Life sciences and biopharma companies strengthen their leadership teams and boards with these Movers & Shakers.

  May 12, 2022

   · 

  8 min read

   · 

  Alex Keown